Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)

NCT07629986 is registered in ClinicalTrials.gov with Fondation Ildys as lead sponsor.

NCT NCT07629986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07629986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)
Lead sponsor
Fondation Ildys
Phase
Observational
Overall status
Recruiting
Start date
March 19, 2026
Completion date
May 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis (cf), pulmonary exacerbation, respiratory infection bacterial